Extracellular vesicles derived from dental mesenchymal stem/stromal cells with gemcitabine as a cargo have an inhibitory effect on the growth of pancreatic carcinoma cell lines in vitro

• DOI: 10.1016/j.mcp.2023.101894
• Publication Date: 2023-01-25T11:06:00Z
• Authors: Daniela Klimova; Jana Jakubechova; Ursula Altanerova; Andreas Nicodemou; Jakub Styk; Tomas Szemes; Vanda Repiska; Cestmir Altaner
• Keywords: QH301-705.5; 5-Fluorouracil; R; Extracellular vesicles; Gemcitabine; Suicide gene; 3. Good health; Cell Line; Pancreatic Neoplasms; Extracellular Vesicles; 03 medical and health sciences; Dental mesenchymal stem/stromal cells; 0302 clinical medicine; Culture Media, Conditioned; 5-Fluorocytosine; Medicine; Humans; Prodrugs; Fluorouracil; Biology (General); Stromal Cells

Extracellular vesicles (EVs) are nowadays a target of interest in cancer therapy as a successful drug delivering tool. Based on their many beneficial biocompatible properties are designed to transport nucleic acids, proteins, various nanomaterials or chemotherapeutics. Extracellular vesicles derived from mesenchymal stem/stromal cells (MSCs) possess their tumor-homing abilities. This inspired us to engineer the MSC's EVs to be packed with chemotherapeutic agents and deliver it as a Trojan horse directly into tumor cells. In our study, human dental pulp MSCs (DP-MSCs) were cultivated with gemcitabine (GCB), which led to its absorption by the cells and subsequent secretion of the drug out into conditioned media in EVs. Concentrated conditioned media containing small EVs (potentially exosomes) significantly inhibited the cell growth of pancreatic carcinoma cell lines in vitro. DP-MSCs were simultaneously engineered to express a suicide gene fused yeast cytosinedeaminase:uracilphosphoribosyltransferase (yCD::UPRT). The product of the suicide gene converts non-toxic prodrug 5-fluorocytosine (5-FC) to highly cytotoxic chemotherapeutic drug 5-fluorouracil (5-FU) in the recipient cancer cells. Conversion of 5-FC to 5-FU had an additional effect on cancer cell's growth inhibition. Our results showed a therapeutic potential for DP-MSC-EVs to be designed for successful delivering of chemotherapeutic drugs, together with prodrug suicide gene therapy system.